Emily Wenande

Clinician and Researcher
Education
MD, PhD
Work areas
Clinician and Research
Orcid ID
0000-0002-5928-5042
Current workplace

Bispebjerg Hospital
Nielsine Nielsens Vej 17, opg. 9, 2.sal D92
2400 København NV.
Denmark

Current research:                                  

As a member of Professor Merete Haedersdal’s lab since 2015, Emily Wenande’s research centers around developing non-surgical treatment strategies for keratinocyte carcinomas and premalignant lesions of the skin. After completing her PhD in topical laser-assisted drug delivery in 2019, Dr. Wenande began an introductory position at the Department of Dermatology where she currently devotes half her time to research activities. Dr. Wenande is furthermore enrolled as a research fellow at Harvard Medical School, Boston, USA.

Main interests

  • Non-surgical management of keratinocyte carcinomas and premalignant lesions
  • Laser dermatology and laser-assisted drug delivery

 

Thesis

Title:

Laser-assisted delivery of topical chemotherapeutics – preclinical investigations

Place of registration:

Københavns Universitet

Year:

2019

Short description

For her work thus far, Dr. Wenande has received the Best Overall Basic Science & Translational Research Award (2020), an Outstanding Early Career Award (2017), and the Dr. Richard E. Fitzpatrick Clinical Research & Innovations Award (2016) from the American Society for Laser Medicine and Surgery. In addition, Dr. Wenande was awarded an honorary grant from the Birgit and Svend Igor Pock-Steens Fund (2017) for her work on laser-assisted drug delivery.

Publications

Wenande E, Hendel K, Mogensen M, Bagger C, Mårtensson NL, Persson DP, Lerche CM, Husted S, Janfelt C, Togsverd-Bo K, Anderson RR, Haedersdal M. Efficacy and Safety of Laser-Assisted Combination Chemotherapy: An Explorative Imaging-Guided Treatment With 5-Fluorouracil and Cisplatin for Basal Cell Carcinoma. Lasers Surg Med. 2021 Jan;53(1):119-128.

Wenande E, Bech-Thomsen N, Haedersdal M. Reduction in actinic keratoses following 9-valent human papilloma virus vaccination. Dermatol Ther. 2020 Jul;33(4):e1345

Wenande E, Anderson RR, Haedersdal M. Fundamentals of fractional laser-assisted drug delivery: An in-depth guide to experimental methodology and data interpretation. Adv Drug Deliv Rev. 2020 Jan 1;153:169-184. 

Wenande E, Phothong W, Bay C, Karmisholt KE, Haedersdal M, Togsverd-Bo K. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization. Br J Dermatol. 2019 Apr;180(4):756-764. 

Wenande E, Tam J, Bhayana B, Schlosser SK, Ishak E, Farinelli WA, Chlopik A, Hoang MP, Pinkhasov OR, Caravan P, Rox Anderson R, Haedersdal M. Laser-assisted delivery of synergistic combination chemotherapy in in vivo skin. J Control Release. 2018 Apr 10;275:242-253.

Publications and releases